Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04384055 · ClinicalTrials.gov registry record
Predicting Outcomes for Covid-19 Using Sonography
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 165
- Enrollment target
NCT04384055: Completed study, sponsored by Stanford University.
NCT04384055 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04384055 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
Study Summary
This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.
Primary Outcome
Composite primary outcome of death, ICU admission, mechanical ventilation, or use of high-flow nasal cannula (categorical)
Interventions
- DIAGNOSTIC_TEST Lung Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2020-03-21 |
| Est. Completion | 2021-11-15 |
What the finished NCT04384055 record still lists
NCT04384055 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Lung Ultrasound is the first listed.
NCT04384055 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04384055 about?
NCT04384055 is a clinical study titled "Predicting Outcomes for Covid-19 Using Sonography". This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early ...
What is the current status of trial NCT04384055?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2020-03-21. Estimated completion is 2021-11-15.
What interventions are being tested in trial NCT04384055?
The interventions under investigation include: Lung Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04384055?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI